These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 26552746)
41. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Lin YG; Kunnumakkara AB; Nair A; Merritt WM; Han LY; Armaiz-Pena GN; Kamat AA; Spannuth WA; Gershenson DM; Lutgendorf SK; Aggarwal BB; Sood AK Clin Cancer Res; 2007 Jun; 13(11):3423-30. PubMed ID: 17545551 [TBL] [Abstract][Full Text] [Related]
42. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo. Xu D; Ma Y; Zhao B; Li S; Zhang Y; Pan S; Wu Y; Wang J; Wang D; Pan H; Liu L; Jiang H Oncol Rep; 2014 May; 31(5):2063-70. PubMed ID: 24603952 [TBL] [Abstract][Full Text] [Related]
43. Thymoquinone Induces Apoptosis in B16-F10 Melanoma Cell Through Inhibition of p-STAT3 and Inhibits Tumor Growth in a Murine Intracerebral Melanoma Model. Hatiboglu MA; Kocyigit A; Guler EM; Akdur K; Nalli A; Karatas E; Tuzgen S World Neurosurg; 2018 Jun; 114():e182-e190. PubMed ID: 29510292 [TBL] [Abstract][Full Text] [Related]
44. Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo. Kundu JK; Liu L; Shin JW; Surh YJ Biochem Biophys Res Commun; 2013 Sep; 438(4):721-7. PubMed ID: 23911786 [TBL] [Abstract][Full Text] [Related]
45. Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer. Shakfa N; Li D; Conseil G; Lightbody ED; Wilson-Sanchez J; Hamade A; Chenard S; Jawa NA; Laight BJ; Afriyie-Asante A; Tyryshkin K; Koebel M; Koti M J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37015760 [TBL] [Abstract][Full Text] [Related]
46. An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels. Zahedi P; Stewart J; De Souza R; Piquette-Miller M; Allen C J Control Release; 2012 Mar; 158(3):379-85. PubMed ID: 22154933 [TBL] [Abstract][Full Text] [Related]
47. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype. Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Connelly L; Barham W; Onishko HM; Sherrill T; Chodosh LA; Blackwell TS; Yull FE Oncogene; 2011 Mar; 30(12):1402-12. PubMed ID: 21076466 [TBL] [Abstract][Full Text] [Related]
49. Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation. Leiva M; Ruiz-Bravo A; Jimenez-Valera M Chest; 2008 Jul; 134(1):20-9. PubMed ID: 18403658 [TBL] [Abstract][Full Text] [Related]
50. The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer. Haria D; Trinh BQ; Ko SY; Barengo N; Liu J; Naora H Am J Pathol; 2015 Aug; 185(8):2298-308. PubMed ID: 26067154 [TBL] [Abstract][Full Text] [Related]
51. Maspin inhibits macrophage phagocytosis and enhances inflammatory cytokine production via activation of NF-κB signaling. Wang Y; Sun L; Song Z; Wang D; Bao Y; Li Y Mol Immunol; 2017 Feb; 82():94-103. PubMed ID: 28064070 [TBL] [Abstract][Full Text] [Related]
52. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336 [TBL] [Abstract][Full Text] [Related]
53. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination. Kobayashi H; Yagyu T; Kondo T; Kurita N; Inagaki K; Haruta S; Kawaguchi R; Kitanaka T; Sakamoto Y; Yamada Y; Kanayama N; Terao T Cancer Res; 2005 Nov; 65(22):10464-71. PubMed ID: 16288038 [TBL] [Abstract][Full Text] [Related]
54. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Greenaway J; Moorehead R; Shaw P; Petrik J Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641 [TBL] [Abstract][Full Text] [Related]
55. Thymoquinone inhibits inflammation, neoangiogenesis and vascular remodeling in asthma mice. Su X; Ren Y; Yu N; Kong L; Kang J Int Immunopharmacol; 2016 Sep; 38():70-80. PubMed ID: 27240137 [TBL] [Abstract][Full Text] [Related]
56. Pronounced transcriptional regulation of apoptotic and TNF-NF-kappa-B signaling genes during the course of thymoquinone mediated apoptosis in HeLa cells. Sakalar C; Yuruk M; Kaya T; Aytekin M; Kuk S; Canatan H Mol Cell Biochem; 2013 Nov; 383(1-2):243-51. PubMed ID: 23943306 [TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537 [TBL] [Abstract][Full Text] [Related]
58. Macrophages modulate migration and invasion of human tongue squamous cell carcinoma. Pirilä E; Väyrynen O; Sundquist E; Päkkilä K; Nyberg P; Nurmenniemi S; Pääkkönen V; Pesonen P; Dayan D; Vered M; Uhlin-Hansen L; Salo T PLoS One; 2015; 10(3):e0120895. PubMed ID: 25811194 [TBL] [Abstract][Full Text] [Related]
59. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats. El-Khouly D; El-Bakly WM; Awad AS; El-Mesallamy HO; El-Demerdash E Toxicology; 2012 Dec; 302(2-3):106-13. PubMed ID: 22982510 [TBL] [Abstract][Full Text] [Related]
60. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice. Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]